GI-155704A

N/A

Report date: 2023/06/14 09:12:32

Base Information

Drug NameGI-155704A
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionMetalloproteases inhibitorsPeptide hydrolase inhibitorsTumor necrosis factor inhibitors
TargetsMetalloproteasesTumor necrosis factorPeptide hydrolase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A